Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology
Jairo R. Temerozo,
Natalia Fintelman-Rodrigues,
Monique Cristina dos Santos,
Eugenio D. Hottz,
Carolina Q. Sacramento,
Aline de Paula Dias da Silva,
Samuel Coelho Mandacaru,
Emilly Caroline dos Santos Moraes,
Monique R. O. Trugilho,
João S. M. Gesto,
Marcelo Alves Ferreira,
Felipe Betoni Saraiva,
Lohanna Palhinha,
Remy Martins-Gonçalves,
Isaclaudia Gomes Azevedo-Quintanilha,
Juliana L. Abrantes,
Cássia Righy,
Pedro Kurtz,
Hui Jiang,
Hongdong Tan,
Carlos Morel,
Dumith Chequer Bou-Habib,
Fernando A. Bozza,
Patrícia T. Bozza,
Thiago Moreno L. Souza
Affiliations
Jairo R. Temerozo
Laboratory on Thymus Research, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Natalia Fintelman-Rodrigues
Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Monique Cristina dos Santos
Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Eugenio D. Hottz
Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Carolina Q. Sacramento
Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Aline de Paula Dias da Silva
Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Samuel Coelho Mandacaru
Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz)
Emilly Caroline dos Santos Moraes
Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Monique R. O. Trugilho
Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz)
João S. M. Gesto
Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz)
Marcelo Alves Ferreira
Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz)
Felipe Betoni Saraiva
Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Oswaldo Cruz Foundation (Fiocruz)
Lohanna Palhinha
Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Remy Martins-Gonçalves
Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Isaclaudia Gomes Azevedo-Quintanilha
Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Juliana L. Abrantes
Instituto de Ciências Biomédicas, Federal University of Rio de Janeiro (UFRJ)
Cássia Righy
Paulo Niemeyer State Brain Institute (IECPN)
Pedro Kurtz
Paulo Niemeyer State Brain Institute (IECPN)
Hui Jiang
MGI Tech Co. Ltd
Hongdong Tan
MGI Tech Co. Ltd
Carlos Morel
Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz)
Dumith Chequer Bou-Habib
Laboratory on Thymus Research, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Fernando A. Bozza
Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz)
Patrícia T. Bozza
Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Thiago Moreno L. Souza
Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
Abstract Background Critically ill 2019 coronavirus disease (COVID-19) patients under invasive mechanical ventilation (IMV) are 10 to 40 times more likely to die than the general population. Although progression from mild to severe COVID-19 has been associated with hypoxia, uncontrolled inflammation, and coagulopathy, the mechanisms involved in the progression to severity are poorly understood. Methods The virome of tracheal aspirates (TA) from 25 COVID-19 patients under IMV was assessed through unbiased RNA sequencing (RNA-seq), and correlation analyses were conducted using available clinical data. Unbiased sequences from nasopharyngeal swabs (NS) from mild cases and TA from non-COVID patients were included in our study for further comparisons. Results We found higher levels and differential expression of human endogenous retrovirus K (HERV-K) genes in TA from critically ill and deceased patients when comparing nasopharyngeal swabs from mild cases to TA from non-COVID patients. In critically ill patients, higher HERV-K levels were associated with early mortality (within 14 days of diagnosis) in the intensive care unit. Increased HERV-K expression in deceased patients was associated with IL-17-related inflammation, monocyte activation, and an increased consumption of clotting/fibrinolysis factors. Moreover, increased HERV-K expression was detected in human primary monocytes from healthy donors after experimental SARS-CoV-2 infection in vitro. Conclusion Our data implicate the levels of HERV-K transcripts in the physiopathology of COVID-19 in the respiratory tract of patients under invasive mechanical ventilation. Video abstract